RankingsPricing
  1. US-listed companies
  2. WEST PHARMACEUTICAL SERVICES INC
  3. Financials
  4. Earnings per share

WEST PHARMACEUTICAL SERVICES INCWST

Market cap
$19.5B
P/E ratio
SummaryFinancials
Period EndEarnings per share (USD)YoY (%)
Dec 31, 20246.8-15.41%
Dec 31, 20238+1.40%
Dec 31, 20227.9-11.47%
Dec 31, 20218.9+89.96%
Dec 31, 20204.7+43.12%
Dec 31, 20193.3+16.79%
Dec 31, 20182.8+37.25%
Dec 31, 20172+4.08%
Dec 31, 20162+47.37%
Dec 31, 20151.3-25.70%
Dec 31, 20141.8+11.18%
Dec 31, 20131.6-32.07%
Dec 31, 20122.4+20.92%
Dec 31, 20102

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)